Pharmena S.A. (WSE:PHR)

Pharmena Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43	43	79	62	88	99
Market Cap Growth	-10.12%	-46.06%	26.79%	-29.20%	-10.89%	67.91%
Enterprise Value	42	32	57	72	96	103
Last Close Price	3.82	3.83	6.41	5.05	7.14	8.12
PE Ratio	-	-	2.73	-	-	-
Forward PE	-	26.88	26.88	26.88	26.88	26.88
PS Ratio	33.40	159.17	264.48	208.60	5.79	9.95
PB Ratio	4.04	3.44	3.56	-9.18	-17.20	-284.09
P/TBV Ratio	4.62	3.78	3.53	-	-	-
P/FCF Ratio	-	-	2.42	39.15	-	-
P/OCF Ratio	-	-	2.39	34.29	-	-
EV/Sales Ratio	33.26	119.44	191.28	241.50	6.34	10.39
EV/EBITDA Ratio	-	-	1.74	-	-	-
EV/EBIT Ratio	-	-	1.74	-	-	-
EV/FCF Ratio	-14.86	-	1.75	45.33	-	-
Debt / Equity Ratio	0.02	0.02	0.01	-1.49	-1.90	-15.83
Debt / EBITDA Ratio	-	-	0.01	-	-	-
Debt / FCF Ratio	-	-	0.01	6.37	-	-
Asset Turnover	0.11	0.01	0.02	0.03	1.38	0.88
Inventory Turnover	0.30	0.12	0.12	0.05	1.82	0.91
Quick Ratio	1.19	2.22	12.84	0.30	0.40	0.37
Current Ratio	13.52	12.98	13.17	0.59	0.71	0.74
Return on Equity (ROE)	-19.70%	-7.29%	350.10%	-	-	-299.40%
Return on Assets (ROA)	-17.02%	-11.30%	111.71%	-21.39%	-22.93%	-33.80%
Return on Capital (ROIC)	-18.03%	-12.13%	159.20%	-63.94%	-51.97%	-56.21%
Return on Capital Employed (ROCE)	-30.60%	-27.00%	146.70%	92.50%	949.40%	3316.20%
Earnings Yield	-5.16%	-2.96%	36.60%	-2.52%	-5.21%	-6.97%
FCF Yield	-6.70%	-6.35%	41.37%	2.55%	-4.02%	-2.48%
Dividend Yield	20.83%	22.19%	13.27%	-	-	-
Buyback Yield / Dilution	-	-	-	-0.25%	-1.25%	-9.87%
Total Shareholder Return	20.83%	22.19%	13.27%	-0.25%	-1.25%	-9.87%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.